This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): liposomal doxorubicin hydrochloride
Description: Nudoxa is doxorubicin hydrochloride encapsulated in liposomes. The mechanism of action of doxorubicin hydrochloride is related to the ability of the antibiotic to bind to DNA and inhibit nucleic acid synthesis.
Additional information available to subscribers only: